Glibenclamide (Glyburide), K+ channel blocker

Alternative names=(R)-limonene 6-monooxygenase, (S)-limonene 6-monooxygenase, (S)-limonene 7-monooxygenase, 1,8-cineole 2-exo-monooxygenase, 2700049B16Rik, 3110031N04Rik, ABC member 16, MDR/TAP subfamily, ABC16, ABC36, ABC37, ABCB1, ABCBB_HUMAN, ABCC8_HUMAN, ABCC9_HUMAN, AI414027, AI449286, ATFB12, ATP binding cassette sub family B (MDR/TAP) member 11, ATP binding cassette sub family C (CFTR/MRP) member 8, ATP binding cassette transporter sub family C member 8 (1), ATP sensitive inward rectifier potassium channel 11, ATP-binding cassette sub-family B member 11, ATP-binding cassette sub-family C member 8, ATP-binding cassette sub-family C member 9, ATP-binding cassette transporter sub-family C member 9, ATP-binding cassette, sub-family C (CFTR/MRP), member 9, AU043990, AW743335, Albendazole monooxygenase, Albendazole sulfoxidase, BIR, BK channel, BK channel beta subunit, BK channel subunit beta-1, BK channel subunit beta-2, BK channel subunit beta-4, BKCA alpha, BKCA alpha subunit, BKTM, BKbeta, BKbeta1, BKbeta2, BKbeta4, BRIC2, BXR, Beta cell inward rectifier subunit, Bile salt export pump, Bsep, C10orf70, CANTU, CAPC, CDGSH iron sulfur domain 1, CDGSH iron-sulfur domain-containing protein 1, CISD1_HUMAN, CMD1O, CP2C9_HUMAN, CP33, CP34, CP3A4_HUMAN, CPC12, CPC8, CPC9, CPCJ, CYP2C, CYP2C10, CYP3, CYP3A, CYP3A3, CYP3A4, CYPIIC9, CYPIIIA3, CYPIIIA4, Calcium activated potassium channel beta 4 subunit, Calcium activated potassium channel subfamily M subunit beta 1, Calcium activated potassium channel subfamily M subunit beta 2, Calcium activated potassium channel subfamily M subunit beta 4, Calcium-activated potassium channel, Calcium-activated potassium channel subunit alpha-1, Calcium-activated potassium channel subunit beta, Calcium-activated potassium channel subunit beta-1, Calcium-activated potassium channel subunit beta-2, Calcium-activated potassium channel subunit beta-4, Charybdotoxin receptor subunit beta-1, Charybdotoxin receptor subunit beta-2, Charybdotoxin receptor subunit beta-4, Cytochrome P-450MP, Cytochrome P450 2C9, Cytochrome P450 3A3, Cytochrome P450 3A4, Cytochrome P450 HLp, Cytochrome P450 MP-4, Cytochrome P450 MP-8, Cytochrome P450 NF-25, Cytochrome P450 PB-1, Cytochrome P450 family 3 subfamily A polypeptide 4, Cytochrome P450 subfamily IIIA polypeptide 4, Cytochrome P450, family 2, subfamily C, polypeptide 9, Cytochrome P450-PCN1, Cytokeratin-associated protein in cancer, D10Ertd214e, Drosophila slowpoke like, FLJ36852, FLJ55736, Glucocorticoid inducible P450, HHF 2, HHF1, HI, HLP, HRINS, Hbeta1, Hbeta2, Hbeta3, Hbeta4, IKATP, IRK 11, Inward rectifier K(+) channel Kir6.2, Inwardly rectifying potassium channel KIR6.2, K(VCA)alpha, K(VCA)beta, K(VCA)beta-1, K(VCA)beta-2, K(VCA)beta-4, KCMA1_HUMAN, KCMB1_HUMAN, KCMB2_HUMAN, KCMB4_HUMAN, KCNJ11, KCNMA, KCNMA1, KCNMB 1, KCNMB 2, KCa1.1, Kir 6.2, LRC26_HUMAN, Large conductance Ca2+ activated K+ channel beta 1 subunit, Large conductance Ca2+ activated K+ channel beta2 subunit, Large conductance calcium activated potassium channel beta 2 subunit, Large conductance calcium dependent potassium ion channel beta 4 subunit, Leucine-rich repeat-containing protein 26, Liver-specific organic anion transporter 1, Lrrc26, MDS029, MGC126680, MGC133230, MGC14684, MGC149605, MGC22431, MGC45260, MGC57945, MGC88320, Maxi K channel, Maxi K channel beta subunit, Maxi K channel subunit beta-1, Maxi K channel subunit beta-2, Maxi K channel subunit beta-4, Maxi Potassium channel alpha, MaxiK, MaxiK channel beta 2 subunit, Microsomal monooxygenase, MitoNEET, NF 25, NR1I2_HUMAN, Nifedipine oxidase, Nuclear receptor subfamily 1 group I member 2, OAT1, OATP-2, OATP-C, ONR 1, OTTHUMP00000020135, OTTHUMP00000215173, OTTHUMP00000215174, OTTHUMP00000215175, OTTHUMP00000236796, OTTHUMP00000236797, OTTHUMP00000236798, OTTHUMP00000236799, Organic anion transporter 1, Orphan nuclear receptor PAR 1, Orphan nuclear receptor PXR, P450 III steroid inducible, P450 MP, P450 PB 1, P450 PCN1, P450, family III, P450C2C, P450C3, P450IIC19, P450IIC9, PAH transporter, PAHT, PAR, PAR q, PFIC 2, PGY4, PHHI, PRR, Para aminohippurate transporter, Potassium channel inwardly rectifing subfamily J member 11, Potassium channel, inwardly rectifying subfamily J member 11, Potassium inwardly rectifying channel J11, Potassium large conductance calcium activated channel subfamily M beta member 1, Potassium large conductance calcium activated channel subfamily M beta member 2, Potassium large conductance calcium activated channel subfamily M beta member 4, Pregnane X receptor, Quinine 3-monooxygenase, RGD1309529, ROAT1, Renal organic anion transporter 1, S-mephenytoin 4-hydroxylase, S22A6_HUMAN, SAKCA, SLC21A6, SLCO1B1, SLO, SO1B1_HUMAN, SUR1delta2, SUR2, SUR2A, SUR2B, SXR, Sister of P glycoprotein, Slo homolog, Slo-alpha, Slo-beta, Slo-beta-1, Slo-beta-2, Slo-beta-4, Slo1, Slowpoke homolog, Sodium-independent organic anion-transporting polypeptide 2, Solute carrier family 21 member 6, Solute carrier family 22 (organic anion transporter) member 6, Solute carrier family 22 member 6, Solute carrier organic anion transporter family member 1B1, Spgp, Steroid and xenobiotic receptor, Sulfonylurea receptor (hyperinsulinemia), Sulfonylurea receptor 1, Sulfonylurea receptor 2, Sulfonylurea-binding protein 2, TNDM 3, TNDM2, Taurochenodeoxycholate 6-alpha-hydroxylase, Xenobiotic monooxygenase, ZCD1, Zinc finger CDGSH type domain 1, bA350O14.10, cytochrome P-450 S-mephenytoin 4-hydroxylase, cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 3, cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 4, cytokeratin-associated protein, flavoprotein-linked monooxygenase, hOAT1, hPAHT, hROAT1, hSlo, hslo beta, pregnane X nuclear receptor variant 2, progressive familial intrahepatic cholestasis 2, subfamily M subunit alpha-1, subfamily M subunit beta-1, subfamily M subunit beta-2, subfamily M subunit beta-4